HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 59, Number 11, December 10, 2002 Correspondence: Submit a response Correspondence: View responses Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carpio, A. Articles by Hauser, W. A. Search for Related Content PubMed PubMed Citation Articles by Carpio, A. Articles by Hauser, W. A. Related Collections Parasitic infections All Epilepsy/Seizures Antiepileptic drugs

Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

From the School of Medicine and Research Institute, University of Cuenca, Ecuador; and G.H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, NY.

Address correspondence and reprint requests to Dr. W. Allen Hauser, 630 W. 168 St., New York, NY; e-mail: wahauser{at}optonline.net

Objective: To determine the risk of seizure recurrence after a first seizure due to neurocysticercosis (NC) and to evaluate risk factors for seizure recurrence, including the influence of antihelminthic treatment.

Methods: The authors prospectively followed 77 patients with a first seizure and active or transitional NC for >7 years (median 24 months).

Results: Thirty-one patients (40.3%) experienced seizure recurrence. Kaplan–Meier estimated recurrence was 22% at 6 months, 32% at 12 months, 39% at 24 months, and 49% at 48 and 84 months. Treatment with an antihelminthic (albendazole) did not influence recurrence. On multivariable analysis, none of the following predicted recurrence: sex, presenting seizure type, classification of NC, localization of cysts, Todd paralysis, neurologic deficits at presentation, EEG abnormalities. Only change in CT predicted recurrence: 22% in patients in whom cysts disappeared and 56% in patients with persistent cysts (p < 0.05). In this latter group, recurrence was associated with persistence of an active lesion. Of those with two seizures, estimated risk of a third seizure was 68% by 6 years after the second seizure.

Conclusions: Seizure recurrence is high after a first acute symptomatic seizure due to NC, but this seems related to persistence of active brain lesions. Recurrence risk is low and in keeping with seizure risk following other brain insults leading to a static encephalopathy in those in whom the NC lesion clears. Patients with NC should receive antiseizure medications until the acute lesion clears on CT. There is no correlation between treatment with antihelminthic agents and seizure recurrence.

This article has been cited by other articles:

				A Carpio, E A Kelvin, E Bagiella, D Leslie, P Leon, H Andrews, W A Hauser, and the Ecuadorian Neurocysticercosis Group Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1050 - 1055. [Abstract] [Full Text] [PDF]

				M. Mazumdar, P. Pandharipande, and A. Poduri Does Albendazole Affect Seizure Remission and Computed Tomography Response in Children With Neurocysticercosis? A Systematic Review and Meta-analysis J Child Neurol, February 1, 2007; 22(2): 135 - 142. [Abstract] [PDF]

				A. I. Bhigjee and S. Rosemberg Optimizing therapy of seizures in patients with HIV and cysticercosis Neurology, December 26, 2006; 67(12_suppl_4): S19 - S22. [Abstract] [Full Text]

				T R Velasco, P A Zanello, C L Dalmagro, D Araujo Jr, A C Santos, M M Bianchin, V Alexandre Jr, R Walz, J A Assirati, C G Carlotti Jr, et al. Calcified cysticercotic lesions and intractable epilepsy: a cross sectional study of 512 patients J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 485 - 488. [Abstract] [Full Text] [PDF]

				V. Rajshekhar and L. Jeyaseelan Seizure outcome in patients with a solitary cerebral cysticercus granuloma Neurology, June 22, 2004; 62(12): 2236 - 2240. [Abstract] [Full Text] [PDF]

				H. H. Garcia, E. J. Pretell, R. H. Gilman, S. M. Martinez, L. H. Moulton, O. H. Del Brutto, G. Herrera, C. A.W. Evans, A. E. Gonzalez, and the Cysticercosis Working Group in Peru A Trial of Antiparasitic Treatment to Reduce the Rate of Seizures Due to Cerebral Cysticercosis N. Engl. J. Med., January 15, 2004; 350(3): 249 - 258. [Abstract] [Full Text] [PDF]

				A. C. Cutter, L. E. Davis, J. Burneo, A. Chakravarty, W. A. Hauser, and A. Carpio Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis Neurology, June 10, 2003; 60(11): 1873 - 1874. [Full Text] [PDF]

Correspondence: